RLAY – relay therapeutics, inc. (US:NASDAQ)
Stock Stats
News
Relay Therapeutics, Inc. (NASDAQ: RLAY) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $16.00 price target on the stock.
Relay Therapeutics, Inc. (NASDAQ: RLAY) had its price target lowered by analysts at The Goldman Sachs Group, Inc. from $20.00 to $18.00. They now have a "buy" rating on the stock.
Relay Therapeutics, Inc. (NASDAQ: RLAY) had its price target lowered by analysts at Stifel Nicolaus from $27.00 to $23.00. They now have a "buy" rating on the stock.
Relay Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Corporate Updates [Yahoo! Finance]
Relay Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Corporate Updates
Form 4 Relay Therapeutics, Inc. For: Mar 27 Filed by: Bergstrom Donald A
Form 4 Relay Therapeutics, Inc. For: Mar 27 Filed by: Rahmer Peter
Form 4 Relay Therapeutics, Inc. For: Mar 27 Filed by: Catinazzo Thomas
Form 4 Relay Therapeutics, Inc. For: Mar 27 Filed by: Adams Brian
Form 144 Relay Therapeutics, Inc. Filed by: Catinazzo Thomas
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.